Stay updated on Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site build/update rather than a change to the study record.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated to v3.5.2; the previous revision v3.5.0 has been removed.SummaryDifference0.0%

- Check55 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1 as the page version. This is a minor update that does not change study content or eligibility details.SummaryDifference0.0%

- Check98 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1, with no user-facing changes to study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.